These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8858688)

  • 1. Cefotaxime failure in pneumococcal meningitis caused by a susceptible isolate.
    Flórez C; Silva G; Martín E
    Pediatr Infect Dis J; 1996 Aug; 15(8):723-4. PubMed ID: 8858688
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis.
    Olivier C; Cohen R; Begué P; Floret D
    Pediatr Infect Dis J; 2000 Oct; 19(10):1015-7. PubMed ID: 11055609
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic failure with high-dose cefotaxime in pneumococcal meningitis].
    Michaus ML; Pérez-Díaz L; de Pablos M; Lezaun MJ; López-Bayón J
    Enferm Infecc Microbiol Clin; 1997 May; 15(5):276-7. PubMed ID: 9376392
    [No Abstract]   [Full Text] [Related]  

  • 4. Occurrence of Streptococcus pneumoniae meningitis during vancomycin and cefotaxime therapy of septicemia in a patient with sickle cell disease.
    Chesney PJ; Davis Y; English BK; Wang WC
    Pediatr Infect Dis J; 1995 Nov; 14(11):1013-5. PubMed ID: 8584345
    [No Abstract]   [Full Text] [Related]  

  • 5. Penicillin-resistant pneumococcal meningitis in Israel.
    Steinberg T; Rachmel A; Samra Z; Ashkenazi S
    Isr J Med Sci; 1997 Nov; 33(11):757-9. PubMed ID: 9434816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections.
    Jacobs RF; Kaplan SL; Schutze GE; Dajani AS; Leggiadro RJ; Rim CS; Puri SK
    Antimicrob Agents Chemother; 1996 Apr; 40(4):895-8. PubMed ID: 8849247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.
    Tan TQ; Schutze GE; Mason EO; Kaplan SL
    Antimicrob Agents Chemother; 1994 May; 38(5):918-23. PubMed ID: 8067771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of cefotaxime treatment in an adult with Streptococcus pneumoniae meningitis.
    Pacheco TR; Cooper CK; Hardy DJ; Betts RF; Bonnez W
    Am J Med; 1997 Mar; 102(3):303-5. PubMed ID: 9217602
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of cefotaxime treatment in two children with meningitis caused by highly penicillin-resistant Streptococcus pneumoniae.
    Guibert M; Chahime H; Petit J; Odièvre M; Labrune P
    Acta Paediatr; 1995 Jul; 84(7):831-3. PubMed ID: 7549311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefotaxime use in pediatric infections.
    Dajani AS
    Diagn Microbiol Infect Dis; 1995; 22(1-2):105-10. PubMed ID: 7587022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
    Stratton CW; Aldridge KE; Gelfand MS
    Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of cefotaxime and meropenem to eradicate meningitis caused by an intermediately susceptible Streptococcus pneumoniae strain.
    Vandecasteele SJ; Verhaegen J; Colaert J; Van Caster A; Devlieger H
    Eur J Clin Microbiol Infect Dis; 2001 Oct; 20(10):751-2. PubMed ID: 11757981
    [No Abstract]   [Full Text] [Related]  

  • 13. [Meningitis by Streptococcus pneumoniae: resistant to cefotaxime?].
    Fernández-Fernández FJ; García-Rodríguez JF; Sesma P; González-González C
    Enferm Infecc Microbiol Clin; 1999 Jan; 17(1):45-6. PubMed ID: 10069118
    [No Abstract]   [Full Text] [Related]  

  • 14. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis.
    Friedland IR; Shelton S; Paris M; Rinderknecht S; Ehrett S; Krisher K; McCracken GH
    Pediatr Infect Dis J; 1993 Mar; 12(3):196-200. PubMed ID: 8451095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Meningitis due to cefotaxime-resistant Streptococcus pneumoniae].
    Martín Fontelos P; Barreiro Casal G; Villota Arrieta J; Pérez Jurado ML; García López M; Mellado Peña MJ; Cilleruelo Ortega MJ
    An Esp Pediatr; 1996 Apr; 44(4):395-6. PubMed ID: 8796948
    [No Abstract]   [Full Text] [Related]  

  • 16. Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro.
    Kühn F; Cottagnoud M; Acosta F; Flatz L; Entenza J; Cottagnoud P
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2487-91. PubMed ID: 12878509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits.
    Täuber MG; Hackbarth CJ; Scott KG; Rusnak MG; Sande MA
    Antimicrob Agents Chemother; 1985 Mar; 27(3):340-2. PubMed ID: 3838872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance.
    Fiore AE; Moroney JF; Farley MM; Harrison LH; Patterson JE; Jorgensen JH; Cetron M; Kolczak MS; Breiman RF; Schuchat A
    Clin Infect Dis; 2000 Jan; 30(1):71-7. PubMed ID: 10619736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis.
    Sloas MM; Barrett FF; Chesney PJ; English BK; Hill BC; Tenover FC; Leggiadro RJ
    Pediatr Infect Dis J; 1992 Aug; 11(8):662-6. PubMed ID: 1523079
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolation in France of a clinical strain of Streptoccus pneumoniae susceptible to amoxycillin and resistant to cefotaxime.
    Vergnaud M; Prévost JN; Malbruny B; Brun J; Leclercq R
    Clin Microbiol Infect; 2000 May; 6(5):283-4. PubMed ID: 11168130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.